Variable | VHA Patients | BSWH Patients | HFHS Patients | ||||||
---|---|---|---|---|---|---|---|---|---|
Model 1a HR (95% CI) | Model 2b HR (95% CI) | Model 3c HR (95% CI) | Model 1a HR (95% CI) | Model 2b HR (95% CI) | Model 3c HR (95% CI) | Model 1a HR (95% CI) | Model 2b HR (95% CI) | Model 3c HR (95% CI) | |
Opioid dose | |||||||||
1 to 50 mg/d | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] |
51 to 100 mg/d | 1.20 (1.10–1.31) | 1.02 (0.93–1.12) | 1.02 (0.93–1.12) | 0.78 (0.60–1.03) | 0.92 (0.71–1.20) | 0.94 (0.72–1.21) | 0.93 (0.83–1.06) | 0.97 (0.86–1.10) | 0.98 (0.86–1.10) |
>100 mg/d | 1.74 (1.49–2.04) | 1.13 (0.94–1.37) | 1.14 (0.94–1.39) | 1.15 (0.72–1.86) | 0.73 (0.41–1.31) | 0.71 (0.40–1.28) | 1.13 (0.84–1.53) | 1.24 (0.92–1.65) | 1.24 (0.92–1.65) |
Arthritis | … | … | 1.18 (1.11–1.25) | … | … | 1.36 (1.18–1.57) | … | … | 1.41 (1.27–1.56) |
Back pain | … | … | 1.49 (1.42–1.57) | … | … | 1.47 (1.30–1.66) | … | … | 1.47 (1.35–1.61) |
Headache | … | … | 1.58 (1.51–1.66) | … | … | 1.93 (1.71–2.18) | … | … | 1.53 (1.42–1.66) |
Musculoskeletal pain | … | … | 1.32 (1.26–1.38) | … | … | 0.74 (0.64–0.85) | … | … | 1.25 (1.12–1.40) |
Neuropathy | … | … | 1.12 (1.07–1.18) | … | … | 1.43 (1.23–1.65) | … | … | 1.33 (1.21–1.46) |
Pain score | … | … | 1.24 (1.22–1.26) | … | … | – | … | … | – |